Colleen M. Kripke

ORCID: 0009-0007-3117-685X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • BRCA gene mutations in cancer
  • Genetic Associations and Epidemiology
  • Nutrition, Genetics, and Disease
  • Cancer Genomics and Diagnostics
  • Liver Disease Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Body Composition Measurement Techniques
  • Metabolism and Genetic Disorders
  • Cancer Research and Treatment
  • Cardiomyopathy and Myosin Studies
  • Biological Research and Disease Studies
  • Liver Disease and Transplantation
  • Frailty in Older Adults
  • Renal Diseases and Glomerulopathies
  • Molecular Biology Techniques and Applications
  • Gene expression and cancer classification
  • Nutrition and Health in Aging
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Genetic Syndromes and Imprinting
  • Retinal Imaging and Analysis
  • Genetics, Bioinformatics, and Biomedical Research
  • Retinal Diseases and Treatments
  • Machine Learning in Bioinformatics
  • Advanced Causal Inference Techniques

University of Pennsylvania
2022-2025

Translational Therapeutics (United States)
2022-2024

Penn Center for AIDS Research
2024

University of Pennsylvania Health System
2024

The Penn Medicine BioBank (PMBB) is an electronic health record (EHR)-linked biobank at the University of Pennsylvania (Penn Medicine). A large variety health-related information, ranging from diagnosis codes to laboratory measurements, imaging data and lifestyle integrated with genomic biomarker in PMBB facilitate discoveries translational science. To date, 174,712 participants have been enrolled into PMBB, including approximately 30% non-European ancestry, making it one most diverse...

10.3390/jpm12121974 article EN Journal of Personalized Medicine 2022-11-29

One of the justifiable criticisms human genetic studies is underrepresentation participants from diverse populations. Lack inclusion must be addressed at-scale to identify causal disease factors and understand causes health disparities. We present genome-wide associations for 2068 traits 635,969 in Department Veterans Affairs Million Veteran Program, a longitudinal study United States Veterans. Systematic analysis revealed 13,672 genomic risk loci; 1608 were only significant after including...

10.1126/science.adj1182 article EN Science 2024-07-18

Importance Polygenic risk scores (PRSs) for coronary heart disease (CHD) are a growing clinical and commercial reality. Whether existing provide similar individual-level assessments of susceptibility remains incompletely characterized. Objective To characterize the agreement CHD PRSs that perform similarly at population level. Design, Setting, Participants Cross-sectional study participants from diverse backgrounds enrolled in All Us Research Program (AOU), Penn Medicine BioBank (PMBB),...

10.1001/jama.2024.23784 article EN JAMA 2024-11-16

Numerous studies have underscored the diagnostic and therapeutic potential of exome or genome sequencing in critically ill pediatric populations. However, an equivalent investigation adults remains conspicuously absent. We retrospectively analyzed whole (WES) data available through PennMedicine Biobank (PMBB) from all 365 young adult patients, aged 18-40 years, with intensive care unit (ICU) admissions at University Pennsylvania Health System who met inclusion criteria for our study. For...

10.1101/2024.03.11.24304088 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-03-15

The study of muscle mass as an imaging-derived phenotype (IDP) may yield new insights into determining the normal and pathologic variations in population. This can be done by 3D abdominal from 12 distinct regions groups using computed tomography (CT) a racially diverse medical biobank. To develop fully automatic technique for assessment CT IDPs preliminarily determine IDP with age sex clinically retrospective was conducted Penn Medicine BioBank (PMBB), research protocol that recruits adult...

10.1038/s41598-024-64603-6 article EN cc-by Scientific Reports 2024-06-26

Abstract The objective of this study is to define CT imaging derived phenotypes for patients with hepatic steatosis, a common metabolic liver condition, and determine its association patient data from medical biobank. There need further characterize steatosis in lean patients, as epidemiology may differ that overweight patients. A deep learning method determined the spleen-hepatic attenuation difference (SHAD) Hounsfield Units (HU) on abdominal scans quantitative measure steatosis. cohort...

10.1038/s41598-023-49470-x article EN cc-by Scientific Reports 2024-01-02

Importance The genetic factors that modulate the reduced penetrance and variable expressivity of heritable dilated cardiomyopathy (DCM) are largely unknown. BAG3 variants have been implicated in both DCM hypertrophic (HCM), nominating as a gene harbors potential modifier DCM. Objective To interrogate clinical traits diseases associated with coding variation. Design, Setting, Participants This was cross-sectional study Penn Medicine BioBank (PMBB) enrolling patients University Pennsylvania...

10.1001/jamacardio.2024.3547 article EN JAMA Cardiology 2024-11-13

In the precision medicine era, genetic diagnoses direct clinical management and lead to improved health outcomes. However, there is scant data on role of race or social determinants (SDH) in access medical genetics evaluation outcomes testing general adult population. This study examines whether race, ethnicity, measures SDH influence results

10.1016/j.gimo.2024.101767 article EN cc-by-nc-nd Genetics in Medicine Open 2024-01-01

Abstract Background Glaucoma is a leading cause of worldwide irreversible blindness. Considerable uncertainty remains regarding the association between variety phenotypes and genetic risk glaucoma, as well impact they exert on glaucoma development. Methods We investigated associations liability for primary open angle (POAG) with wide range potential factors to assess its incident glaucoma. The phenome-wide study (PheWAS) approach was applied determine POAG polygenic score (PRS) in 377, 852...

10.1186/s12967-024-05152-4 article EN cc-by Journal of Translational Medicine 2024-04-15

Germline genetic testing is recommended for an increasing number of conditions with underlying etiologies, the results which impact medical management. However, underutilized in clinics due to system, clinician, and patient level barriers. Behavioral economics provides a framework create implementation strategies, such as nudges, address these multi-level barriers increase uptake where

10.1186/s13012-024-01385-5 article EN cc-by Implementation Science 2024-08-19

Introduction: Early and accurate classification of transthyretin amyloidosis (ATTR) is crucial for improving patient outcomes. However, nonspecific symptoms heterogeneous disease variations have made ATTR diagnosis challenging. Leveraging advancements in machine learning (ML) large language models (LLMs), this study aims to enhance diagnostic accuracy by analyzing electronic health records (EHRs) data. Hypothesis: Can the integration innovative feature formulation improve performance ML...

10.1161/circ.150.suppl_1.4147767 article EN Circulation 2024-11-12
Coming Soon ...